Rockville, Maryland — According to state and local economic development sources MilliporeSigma/BioReliance Corporation plans to invest $286,000,000.00 to build out 250,000 square feet of new space in Rockville. The company plans to occupy the new space at 9820 Darnestown Road in Rockville, on or about July 1, 2024. According to the company website MilliporeSigmas BioReliance testing services is the leading GMP and GLP testing services provider for the development of your therapeutics. Regulatory bodies such as the US Food & Drug Administrators (FDA) and the Medicines and Healthcare products Regulatory Agency (MHRA) require products to be tested for compliance before release. Our clients include producers of traditional pharmaceuticals, medical devices, chemicals and other products, as well as biopharmaceuticals. In biopharmaceutical manufacturing, every product produced for preclinical and clinical studies, as well as the global pharmaceutical markets, require testing to demonstrate regulatory guideline compliance. Our biopharmaceutical testing services use a wide range of tests and technologies to ensure your product is compliant and safe for human use.

To learn more about MilliporeSigma/BioReliance Corporation, visit http://www.bioreliance.com/

Company Contact:
Benoit Gourdier, Senior VP & General Manager BioReliance
https://www.linkedin.com/in/benoit-gourdier/
301-738-1000

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.